A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients.
This device recovers and recycles the blood that is spilled during surgery. It then processes and returns the blood to the patient through autotransfusion. By using the patient's own blood, there is a lower need for donor blood, and a lesser risk of reaction from the transfusion.
HemoSep, as the new device is called, has succeeded in clinical trials and has been approved for use in Europe and Canada.